WallStreetZenWallStreetZen

NASDAQ: AGIO
Agios Pharmaceuticals Inc Stock Ownership - Who owns Agios Pharmaceuticals?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Agios Pharmaceuticals Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Sarah GheuensMed2026-08-0430,000$30.48
$914.40kSell
Sarah GheuensChief Medical Officer2026-07-014,007$37.56
$150.50kSell
James William BurnsChief Legal Officer2026-04-023,280$34.71
$113.85kSell
Krishnan ViswanadhanChief Corp Dev Strategy2026-04-022,959$34.71
$102.71kSell
Sarah GheuensChief Medical Officer2026-04-022,940$34.71
$102.05kSell
Cecilia JonesChief Financial Officer2026-04-023,141$34.71
$109.02kSell
Brian GoffChief Executive Officer2026-04-0212,472$34.71
$432.90kSell
Tsveta MilanovaChief Commercial Officer2026-04-023,262$34.71
$113.22kSell
Brian GoffChief Executive Officer2026-04-026,596$34.71
$228.95kSell
Krishnan ViswanadhanChief Corp Dev Strategy2026-03-052,959$27.80
$82.26kSell

1 of 5

AGIO insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when AGIO insiders and whales buy or sell their stock.

AGIO Shareholders

What type of owners hold Agios Pharmaceuticals Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Celgene European Investment Co LLC9.83%5,867,279$193.33MInsider
Robert Nelsen6.65%3,969,968$130.81MInsider
Arch Venture Fund VII LP5.17%3,088,590$101.77MInsider
Celgene Corp4.16%2,486,157$81.92MInsider
Flagship Ventures Fund 2007 LP3.23%1,930,369$63.61MInsider
Tak W. Mak0.91%545,454$17.97MInsider
David P. Schenkein0.34%205,324$6.77MInsider
Brian Goff0.31%184,508$6.08MInsider
Kevin P. Starr0.31%184,386$6.08MInsider
Jacqualyn A. Fouse0.26%154,156$5.08MInsider

1 of 3

AGIO vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
AGIO0.11%32.66%Net SellingNet Selling
ADMA0.09%25.11%Net SellingNet Selling
RAPP0.11%31.54%Net SellingNet Selling
GHRS0.08%21.86%
VCEL0.11%10.19%Net SellingNet Selling
View Top Biotech Stocks

Agios Pharmaceuticals Stock Ownership FAQ

Who owns Agios Pharmaceuticals?

Agios Pharmaceuticals (NASDAQ: AGIO) is owned by 0.11% institutional shareholders, 32.66% Agios Pharmaceuticals insiders, and 67.23% retail investors. Celgene European Investment Co LLC is the largest individual Agios Pharmaceuticals shareholder, owning 5.87M shares representing 9.83% of the company. Celgene European Investment Co LLC's Agios Pharmaceuticals shares are currently valued at $197.20M.

If you're new to stock investing, here's how to buy Agios Pharmaceuticals stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.